CJMB · CALLAN JMB INC.

Callan JMB Inc. faces a critical compliance challenge with Nasdaq Listing Rule 5550(b)(1), which mandates maintaining at least $2,500,000 in stockholders' equity for continued listing on The Nasdaq Capital Market. The deficiency letter received on April 7, 2026, triggers an initial 45-calendar-day window ending May 22, 2026, during which the Company plans to submit a compliance plan. If Nasdaq accepts the plan at its discretion, an additional extension of up to 180 calendar days from the notice date—until October 4, 2026—could be granted to demonstrate compliance. While the notice does not immediately impact the listing or trading of the Company's common stock under the symbol 'CJMB,' failure to resolve the issue risks delisting, which could significantly impair liquidity, investor confidence, and access to capital markets. The filing emphasizes uncertainties, noting no guarantees of plan acceptance or successful compliance, underscoring the heightened risk to shareholders.